# Randomized Comparison of Optimal Medical Therapy and Percutaneous Recanalization for Chronic Total Occlusion (COMET-CTO)

> **NCT02964975** · PHASE4 · COMPLETED · sponsor: **Clinical Centre of Serbia** · enrollment: 100 (actual)

## Conditions studied

- Chronic Total Occlusions of Coronary Arteries

## Interventions

- **PROCEDURE:** Percutaneous coronary intervention
- **DRUG:** Optimal medical therapy

## Key facts

- **NCT ID:** NCT02964975
- **Lead sponsor:** Clinical Centre of Serbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-11-30
- **Final completion:** 2017-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02964975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02964975, "Randomized Comparison of Optimal Medical Therapy and Percutaneous Recanalization for Chronic Total Occlusion (COMET-CTO)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02964975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*